Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HIFU Therapy vs Active Surveillance in Low Risk Prostate Cancer
NCT03531099Phase 3Active, not recruiting
- Sponsor
- Hospices Civils de Lyon
- Start
- Oct 2018
- Primary completion
- Oct 2026
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in prostate cancer (PCa) (2 arms), sponsored by Hospices Civils de Lyon. Primary endpoint: Proportion of patients who needed to seek radical treatment at 48 months. Started Oct 2018; status: active, not recruiting.
02
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT03531099.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03531099.